This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Fecal transplantation (also known as stool transplantation, fecal bacteriotherapy, fecal transplants, or fecal transplants) is a medical procedure involving the transplantation of healthy fecal matter, usually from a donor, into the intestinal tract of a patient who has a gastrointestinal (GI) disorder or infection. The goal of the procedure is to restore the balance of beneficial bacteria in the gut, which is believed to be altered in a variety of GI conditions. Fecal transplantation is used to treat a variety of conditions, including recurrent Clostridium difficile infection, inflammatory bowel disease, irritable bowel syndrome, and other GI diseases. The procedure involves the collection of healthy fecal matter from a donor, which is then processed for safety and introduced into the patient's intestines via a colonoscopy or enema. The donor must be free of infectious diseases and meet certain criteria for the procedure to be successful. The process of fecal transplantation has been used for centuries. In traditional Chinese medicine, it has been used to treat a variety of conditions, including diarrhea, intestinal parasites, and constipation. In recent years, fecal transplantation has also been studied in modern medicine, with a number of clinical trials and observational studies showing positive results. The procedure is believed to work by restoring the balance of bacteria in the gut, which is thought to be disrupted in a variety of GI disorders. By introducing healthy bacteria from the donor, the patient's gut flora can be restored and the symptoms of the disorder can be alleviated. Fecal transplantation has been found to be safe and effective in treating a variety of conditions, although more research is needed to determine the long-term safety and efficacy of the procedure.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States